Pulse Biosciences, Inc.
PLSE
$16.49
-$0.56-3.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.17M | -16.80M | -19.39M | -12.68M | -11.38M |
| Total Depreciation and Amortization | 273.00K | 283.00K | 287.00K | 294.00K | 298.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.19M | 5.68M | 6.80M | 2.98M | 2.05M |
| Change in Net Operating Assets | 899.00K | -2.69M | 3.16M | 380.00K | 638.00K |
| Cash from Operations | -12.81M | -13.52M | -9.14M | -9.02M | -8.40M |
| Capital Expenditure | -103.00K | -45.00K | -53.00K | -38.00K | -29.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.00K | -- | -- | -- | -- |
| Cash from Investing | -123.00K | -45.00K | -53.00K | -38.00K | -29.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 14.81M | 48.26M | 61.84M | 13.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -59.00K | 56.00K | -278.00K |
| Cash from Financing | 0.00 | 14.81M | 48.20M | 61.90M | -265.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.93M | 1.24M | 39.01M | 52.84M | -8.69M |